- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07603089
Exploring the Link Between Menopause, Glucose Control, and Frozen Shoulder in Women (MENO-FROST)
Exploring the Association Between Menopausal Status, Metabolic Health, and Frozen Shoulder in Women: a Cross-sectional Observational Study
Background
Frozen shoulder (FS) is a common condition and affects how the shoulder moves, making it very stiff and sore. The shoulder joint becomes inflamed and tightened due to scarring in the joint called fibrosis. It can take years to get better, and for around 50% of individuals the symptoms last even longer. FS causes a profound negative impact on physical and mental health, including disturbed sleep, low mood, difficulty performing everyday activities and, in many cases, are unable to continue working. FS affects around 1 in 10 people, and almost twice as many women as men between the ages of 40-60 years, but it is unknown why. It is thought to either be related to changes in sex hormones during the menopause, or due to the way the body handles sugar and fat, which changes with the menopause. However, associations between the menopause transition and FS are not well established and previous evidence has been poor quality. Current treatments include physiotherapy, a steroid injection or surgery but none of these treat the underlying cause of FS. Women with FS said they would like to know why they developed FS and more early treatment options to avoid a long recovery or an operation.
Aim This study aims to understand if there is a link between the menopause, changes in blood sugar levels and FS in women.
Plan In Part 1, women who have had FS will fill in an electronic questionnaire to give us information about their menopause status at the onset of FS, how long their symptoms lasted, what treatments they tried, and if they had any other health conditions. This will enable us to determine the relationship between the menopause and the onset of FS.
In Part 2, the investigators will invite 18 perimenopausal women with recently diagnosed FS and 18 matched women without FS to attend a one-day visit at the University of Nottingham. The investigators will measure their blood sugar levels over two weeks using a small monitor on their arm. The investigators will assess their menopause symptoms and shoulder related outcomes using validated questionnaires. The investigators will assess their shoulder movement and measure body fat and muscle levels, physical activity levels, diet, and take a blood sample to test sex hormones, inflammation and lipids, as well as markers related to frozen shoulder. This will help us to assess the relationship between blood glucose control and the onset of FS in perimenopausal women.
Impact This research will help us understand if there's a link between menopause, blood sugar control, and FS. It could lead to new clinical trials testing treatments early in FS, such as a glucose lowering medication or hormone therapy, to help women recover faster and avoid surgery. This may improve clinical outcomes in women with FS and reduce costs associated with treating FS. This important question came directly from patients and has not been studied in depth before. The investigators plan to share the results widely through health newsletters, podcasts, research conferences, and medical journals.
Panoramica dello studio
Stato
Condizioni
Tipo di studio
Iscrizione (Stimato)
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Metodo di campionamento
Popolazione di studio
Part 1: Any woman over 18 years of age with a current or previous history of frozen shoulder
Part 2: Perimenopausal women with recent diagnosis of primary frozen shoulder and matched controls
Descrizione
Part 1
Inclusion criteria:
• Any women > 18 years with a history of frozen shoulder diagnosed by a clinician
Exclusion criteria:
• Any women without a clear previous diagnosis of frozen shoulder
Part 2:
Inclusion criteria:
- Perimenopausal women (self-assessment)
- Aged 40-60 years
- Diagnosed with FS within the last 12 months OR
- Matched controls (women aged 40-60 years without FS).
Exclusion criteria:
- Diabetes mellitus,
- Thyroid dysfunction,
- Secondary FS (e.g. posttraumatic),
- Use of medications influencing hormonal or metabolic parameters (e.g. hormone replacement therapy [HRT].
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Menopause status at frozen shoulder onset
Lasso di tempo: Baseline
|
Part 1: • Self-reported menopause status at the time of FS onset
|
Baseline
|
|
Estimated HbA1c
Lasso di tempo: 14 days
|
Part 2: Estimated HbA1c from continuous glucose monitoring (CGM)
|
14 days
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Type of menopause
Lasso di tempo: Baseline
|
Part 1: Type of menopause
|
Baseline
|
|
Frozen shoulder duration
Lasso di tempo: Baseline
|
Part 1: Duration of FS symptoms
|
Baseline
|
|
BMI and waist circumference
Lasso di tempo: Baseline
|
Part 2: weight and height will be combined to report BMI in kg/m^2
|
Baseline
|
|
Serum fasting lipids
Lasso di tempo: Baseline
|
Part 2: serum fasting lipid concentration
|
Baseline
|
|
Step count
Lasso di tempo: 14 days
|
Part 2: activity data from ActivPAL
|
14 days
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 26018
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .